Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice

Life Sciences

Volumn 60, Issue 19, 1997, Pages 1699-1708

  Kamei, Junzo ^a   Saitoh, Akiyoshi ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

diabetic mice; dopamine; limbic forebrain; serum glucose level; spleen; spontaneous locomotor activity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUCOSE; HOMOVANILLIC ACID; INSULIN ZINC SUSPENSION; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; GLUCOSE BLOOD LEVEL; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; SPLENECTOMY; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; TURNOVER TIME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOPAMINE; GLUCOSE; HOMOVANILLIC ACID; INSULIN; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PROSENCEPHALON; SPLEEN; SPLENECTOMY;

EID: 0030914579     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00112-4     Document Type: Article

References (38)

1. M.K. POPKIN, A.L. CALLIES, R.D. LENTZ, E.A. COLON and D.E. SOUTHERLAND, Arch. Gen. Psychiat. 45 64-68 (1988).
2. P.J. LUSTMA, D.A. SKOR, R.M. CARNEY, J.V. SANTIAGO and P.E. CRYER, Lancet i 588 (1983)
3. P.J. LUSTMA, L.S. GRIFFITH, R.E. CLOUSE and P.E. CRYER, J. Nerv. Ment. Dis. 174 736-742 (1986).
4. C. RYAN, C., A. VEGA C. LONGSTREET and A. DRASH, J. Consult. Clin. Psychol. 52 335-342 (1984).
5. C. RYAN, C., A. VEGA, C. LONGSTREET and A. DRASH, Pediatrics 75 921-927 (1985).
6. M. BITAR, M. KOULU, S.I. RAPOPORT and M. LINNOILA, 1986, J. Pharmacol. Exp. Ther. 236 432-437 (1986).
7. C.W. BRADBERRY, D.H. KARASIC, A.Y. DEUTCH and R.H. ROTH, J. Neural. Transm. 78 221-229 (1989).
8. J. KAMEI, A. SAITOH, Y. IWAMOTO, M. FUNADA T. SUZUKI, M. MISAWA H. NAGASE and Y. KASUYA, Neurosci. Lett. 178 69-72 (1994).
9. M. SÁKOVIC, I. SABOLIC and Z. LACKOVIC, J. Neural. Transm. 100 137-145 (1995).
10. F.J. MARTÍN, J.M. MÍGUEZ and M. ALDEGUNDE, Biogenic Amines 11 305-311 (1995).
11. J. KAMEI, Y. OHHASHI, T. AOKI, N. KAWASHIMA and Y. KASUYA Brain Res. 571 199-203 (1992).
12. J. KAMEI, N. KAWASHIMA and Y. KASUYA, Brain Res. 592 101-105 (1992).
13. J. KAMEI, N. KAWASHIMA and Y. KASUYA, Life Sci. 52 53-60 (1992).
14. J. KAMEI, Y. IWAMOTO, M. MISAWA, H. NAGASE and Y. KASUYA, Neuropharmacology 33 1553-1558 (1994).
15. J. KAMEI, A. SAITOH, M. OHSAWA T. SUZUKI, M. MISAWA, H. NAGASE and Y. KASUYA, Eur. J. Pharmacol. 276 131-135 (1995).
16. J. KAMEI, Y. IWAMOTO, H. HITOSUGI, M. MISAWA, H. NAGASE and Y. KASUYA, Neurosci. Lett. 165 141-143 (1994).
17. J. KAMEI, N. KAWASHIMA and Y. KASUYA, Brain Res. 576 139-142 (1992)
18. J. KAMEI and A. SAITOH, Neurosci. Lett. 210 57-60 (1996).
19. B. CONRAD, E. WEIDMANN, G. TRUCCO, W.A. RUDERT, R. BEHBOO, C. RICORDI, H. RODRIQUEZ-RILO, D. FINEGOLD and M. TRUCCO, Nature 371 351-355 (1994).
20. H. TOYODA, B. FORMBY, D. MAGALONG, A. REDFORD, E. CHAN, S. TAKEI and M.A. CHARLES, Immunol. Lett. 39 283-288 (1994).
21. P. BARNEOUND, J.M. RIVET, S. VITELLO, M. LE. MOAL and P.J. NEVEA Immunol. Lett. 18 201-204 (1988).
22. K.M. DUBOWSKI, Clin. Chem. 8 215-235 (1962).
23. M. HIRABAYASHI and M.R. ALAM, Pharmacol. Biochem. Behav. 15 925-932 (1981).
24. J. KAMEI, M. OHSAWA, A. SAITOH, Y. IWAMOTO, T. SUZUKI, M. MISAWA, H. NAGASE and Y. KASUYA, J. Pharmacol. Exp. Ther. 274 700-706 (1995).
25. R.E. STRECKER, G.F. STEINFELS and B.L. JACOBS, Brain Res. 260 317-321 (1983).
26. M.E. TRULSON, T. CRISP and V.M. TRULSON, 1983, Life. Sci., 32 2555-2564 (1983).
27. B.H.C. WESTERINK, B.H.C., J. Pharm. Pharmacol. 33 601-602 (1981).
28. H. ACHA-ORBEA L. STEINMAN and H.O. MCDEVITT, Annu. Rev. Immunol. 7 371-405 (1989).
29. M. NAGATA, K. YOKONO, M. HAYAKAWA, Y. KAWASE, N. HATAMORI, W. OGAWA, K. YONEZAWA, K. SHII. and S.J. BABA, Immunology 143 1155-1162 (1989).
30. B. FORMBY, N. HOSSZUFALUSI, E. CHAN, N. MILLER, M. TERUYA, S. TAKEI and M.A. CHARLES, Autoimmunity 12 95-102 (1992).
31. Y.T. KIM. and C. STEINBERG, C., Diabetes 33 771-777 (1984).
32. A.A. LIKE and A.A. ROSSINI, Science 193 415-417 (1976).
33. K.C. HEROLD, T.N. BLOCH, V. VEZYS and Q. SUN, Diabetes 44 354-359 (1995).
34. M. KRISTEN, J. BRETT, S. RODOFF, S. OGAWA D. STEN and H. VLASSARA, Proc. Natl. Acad. Sci. USA. 87 9010-9014 (1990).
35. D.J.J. CARR, Prog. Neuroendocrinimmunol. 1 8-14 (1988).
36. G.C. MILLER, A.J. MURGO and N.P. PLOTNIKOFF, Immunopathol. 26 446-451 (1983).
37. D.E. VAN EPPS and L. SALAD, J. Immunol. 132 3046-3053 (1984).
38. F.H. HUCKLEBRIDGE, B.N. HUDSPITH, J. MUHAMED, P.M. LYDYARD and J. BROSTOFF, Brain Behav. Immun. 3 183-189 (1989).